Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 3,668,428
- 试验地点
- 4
- 主要终点
- Proportion of participants with documented influenza vaccine receipt
研究概览
简要总结
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed.
KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.
详细描述
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular events and mortality in select populations. However, the potential population level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed.
KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.
The study will evaluate an operational directive at KPNC and KPMAS. Eligible participants will be randomized into 4 study arms, corresponding to the messaging received at two different vaccine communication touchpoints (Touchpoint 1/Touchpoint 2) during the 2024-2025 influenza season:
- CV-focused nudge communication/CV-focused nudge communication
- CV-focused nudge communication/Usual care communication
- Usual care communication/CV-focused nudge communication
- Usual care communication/Usual care communication
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥18 years
- •Active KPNC or KPMAS member
- •≥6 months of continuous health plan coverage and prescription drug benefit before September 1, 2024
- •Evidence of member access to the KP HealthConnect® Portal and/or a listed registered email address
- •No documented influenza vaccination during the 2024-2025 influenza season prior to randomization
排除标准
- •Unable to receive or opted out of receiving health system messaging
- •Other exclusion that prevents messaging outreach.
- •Unknown service area or medical center affiliation.
结局指标
主要结局
Proportion of participants with documented influenza vaccine receipt
时间窗: up to 8 months
Proportion of participants with documented influenza vaccine receipt after randomization.
次要结局
- Time to influenza vaccine receipt(up to 8 months)